Marinemax Inc: Form 10-Q for the period ended Mar 31, 2024
Filed with the SEC on Apr 25, 2024 and accepted by EDGAR at Apr 25, 2024, 20:00 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-01-01 to 2024-03-31 | $582.9m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2023-10-01 to 2024-03-31 | $1.11bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2024-01-01 to 2024-03-31 | $392.5m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2023-10-01 to 2024-03-31 | $744.3m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2024-01-01 to 2024-03-31 | $190.4m | us-gaap:GrossProfit |
| Gross profit | 6 months2023-10-01 to 2024-03-31 | $365.9m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2024-01-01 to 2024-03-31 | $169.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2023-10-01 to 2024-03-31 | $325.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2024-01-01 to 2024-03-31 | $21.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2023-10-01 to 2024-03-31 | $40.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2024-01-01 to 2024-03-31 | $19.4m | us-gaap:InterestExpense |
| Interest expense | 6 months2023-10-01 to 2024-03-31 | $37.7m | us-gaap:InterestExpense |
| Income tax | 3 months2024-01-01 to 2024-03-31 | $578.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2023-10-01 to 2024-03-31 | $367.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-01-01 to 2024-03-31 | $1.6m | us-gaap:NetIncomeLoss |
| Net income | 6 months2023-10-01 to 2024-03-31 | $2.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-01-01 to 2024-03-31 | $0.07 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2023-10-01 to 2024-03-31 | $0.11 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-01-01 to 2024-03-31 | $0.07 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2023-10-01 to 2024-03-31 | $0.11 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-01-01 to 2024-03-31 | 22,999,229 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2023-10-01 to 2024-03-31 | 22,903,840 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2023-10-01 to 2024-03-31 | −$111.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2023-10-01 to 2024-03-31 | $28.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2024-03-31 | $216.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-03-31 | $1.29bn | us-gaap:AssetsCurrent |
| Total assets | At period end2024-03-31 | $2.63bn | us-gaap:Assets |
| Current liabilities | At period end2024-03-31 | $1.05bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-03-31 | $1.69bn | us-gaap:Liabilities |
| Long-term debt | At period end2024-03-31 | $372.6m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2024-03-31 | $33.8m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | At period end2024-03-31 | $736.7m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2024-03-31 | $931.3m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-24-048260. Last ingested by Listed: Oct 24, 2026, 15:03 ET. Listed shows no prices and gives no investment advice.